This meeting took place in 2012



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

NF-kappaB Signaling and Biology: From Bench to Bedside (X1)


Organizer(s) Michael Karin and Hao Wu
March 18—23, 2012
Whistler Conference Centre • Whistler, BC Canada
Abstract Deadline: Nov 16, 2011
Late Abstract Deadline: Dec 20, 2011
Scholarship Deadline: Nov 16, 2011
Early Registration Deadline: Jan 18, 2012

Sponsored by Onyx Pharmaceuticals, Inc.

Joint Meeting: Ubiquitin Signaling (X2)

Summary of Meeting:
The regulation and function of NF-kB have captivated molecular and cellular biologists, as well as immunologists, pathologists and drug developers for many years. Studies of NF-kB and its regulation have taught us many fundamental lessons and principals in basic biological sciences as well as in biomedicine. Although rapidly reaching maturity, with 25 years since its discovery, the NF-kB field remains vibrant and fertile, and never ceases to amaze with new groundbreaking discoveries. The Keystone Symposia meeting on NF-kB Signaling and Biology: From Bench to Bedside will cover the basic biochemistry of NF-kB signaling; how NF-kkB accomplishes its main job as a transcription factor; the roles of the NF-kB system in immunity and inflammation; how NF-kB controls cell death, survival and metabolism; and how all of these functions go awry during disease development – something that we have learned both from studies of genetically altered mice and from studies of human genetic defects and pathology. Finally, this meeting will teach us how we might fix and cure these problems through the pharmacological targeting of the NF-kB system. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Ubiquitin Signaling, which will share a keynote address and three plenary sessions with this meeting.

View Meeting Program

Scholarships/Awards

Keystone Symposia Future of Science Fund Scholarship Recipients

Vasant Chellappa
Massachusetts General Hospital, USA

Kivia A Pontes de Oliveira
Max Delbrück Center for Molecular Medicine, Germany

Andrew Oberst
University of Washington, USA

Andrea Oeckinghaus
Columbia University, USA

Amanda Opaluch
Sanford-Burnham Medical Research Institute, USA

Parameswaran Ramakrishnan
Case Western Reserve University, USA

Jevgenia Rudenko
NIAMS, National Institutes of Health, USA

National Institute of Allergy and Infectious Diseases (NIAID) Scholarship Recipients

Katy Billot
Institut Cochin INSERM U1016, France

Dirk Brenner
Luxembourg Institute of Health, Luxembourg

Smarajit Polley
University of California, San Diego, USA

Michelle Vincendeau
Hemlmholtz Zentrum München, Germany